// App-Quantinova.ai

351 : Magnetic resonance assessment of hypothermic neuroprotection amongst babies born inside or outside of a cooling centre: a secondary analysis of the HELIX Trial

Researchers

Presenter

  • Phoebe Ivain

Principal Investigators

  • Vijay Kumar

  • Vaisakh Krishnan

  • Stuti Pant

  • Josephine I. Mendoza

  • Maria Moreno Morales

  • Deepika Shukla

  • Prathik Bandiya

  • Chinnathambi N. Kamalarathnam

  • Mohamed Sajjid

  • Swati A. Manerkar

  • Jayashree A. Mondkar

  • Ismat Jahan

  • Sadeka C. Moni

  • Mohammod Shahidullah

  • Ranmali Rodrigo

  • Samanmali Sumanasena

  • Radhika Sujatha

  • Ronit M. Pressler

  • Seetha Shankaran

  • Sudhin Thayyil

Medical Centers

  • Imperial College, London, PALAKKAD, Kerala, India

  • Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Dhaka, Bangladesh

  • University of Kelaniya, Ragama, Western Province, Sri Lanka

  • Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, India

  • IOG and Govt. Hospital for Women and Children, Chennai, Tamil Nadu, India

  • Indira Gandhi Institute of Child health, Bangalore, Karnataka, India

  • Wayne State University School of Medicine, Austin, TX, United States

  • Madras Medical College, Chennai, Chennai 85, Tamil Nadu, India

  • Imperial College London, london, England, United Kingdom

  • Great Ormond Street Hospital, London, England, United Kingdom

  • SAT Hospital, Government Medical College, Thiruvananthapuram, Thiruvananthapuram, Kerala, India

  • LTM Medical college & GeneralHospital, Mumbai, Maharashtra, India

Locations

  • India

  • United States

  • Bangladesh

  • United Kingdom

  • Sri Lanka

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Genetic Disorder

Disease

  • Encephalopathy

  • HELIX syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved